Offer - Urjas Oil for just ₹ 1 X
Mitinab 400 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Chronic Myelogenous Leukemia are some of its major therapeutic uses. Other than this, Mitinab 400 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Mitinab 400 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Mitinab 400 Mg Tablet have been listed ahead. Such side effects of Mitinab 400 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Mitinab 400 Mg Tablet's effect during pregnancy is Severe and Moderate while nursing. In addition, Mitinab 400 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Mitinab 400 Mg Tablet related warnings section.
Other contraindications of Mitinab 400 Mg Tablet have been discussed in the sections ahead.
Besides this, Mitinab 400 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mitinab 400 Mg Tablet is considered not safe while driving, and is not addictive.
Mitinab 400 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Mitinab 400 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Mitinab. If you are pregnant, do not take Mitinab without a doctor's advice.
Is the use of Mitinab 400 Mg Tablet safe during breastfeeding?
Mitinab can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mitinab 400 Mg Tablet on the Kidneys?
Kidney can be affected by Mitinab. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Mitinab 400 Mg Tablet on the Liver?
Very few cases of side effects of Mitinab on the liver have been reported.
What is the effect of Mitinab 400 Mg Tablet on the Heart?
Mitinab may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Mitinab 400 Mg Tablet unless your doctor advises you to do so -
Is this Mitinab 400 Mg Tablet habit forming or addictive?
Mitinab 400 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mitinab 400 Mg Tablet can make you feel drowsy.
Is it safe?
Mitinab 400 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Mitinab 400 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Mitinab 400 Mg Tablet
Taking Mitinab 400 Mg Tablet with food is safe.
Interaction between Alcohol and Mitinab 400 Mg Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Mitinab 400 Mg Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869